3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erythematosus Study Protocol 2

Active, not recruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

March 27, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Systemic Lupus Erythematosus (SLE)
Interventions
BIOLOGICAL

Blood sample

Total volume of blood (on each sampling occasion): 54,5mL.

BIOLOGICAL

Urine sample

Urine: 100 mL which will be centrifuged. The pellet will be frozen, and the urine supernatant will be aliquoted.

BIOLOGICAL

Saliva sample

Saliva: will be collected in special container for saliva microbiome and methylation.

BIOLOGICAL

Stool sample

Stool: One sample for microbiome to be sent to the biobank, frozen at -80 °C.

BIOLOGICAL

Tissue sample

"Tissue samples for organ-specific manifestations:~* Kidney tissue in lupus nephritis: one small fragment of the fresh kidney biopsy will be stored in a 10% dimethyl sulfoxide (DMSO) solution (slow freezing to -80 °C) until shipment.~* Skin tissue (at selected centers) from inflamed lesion and non-inflamed skin from the gluteal region will be obtained through punch biopsy and stored in a 10% dimethyl sulfoxide (DMSO) solution (slow freezing to -80 °C) until shipment.~* Synovial tissue (at selected centers) will be obtained through ultrasound-directed arthroscopy and stored in a 10% dimethyl sulfoxide (DMSO) solution (slow freezing to -80 °C) until shipment.~* Aspirate from swollen lymph nodes (at selected centers) will be obtained and stored in a 10% dimethyl sulfoxide (DMSO) solution (slow freezing to -80 °C) until shipment."

Trial Locations (1)

29200

CHU Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER